Search Clinical Trials

Clinical Trials Search Results

The results of your search are listed below. To view the details of a trial or study, click on the see details >> link. Or start a new search.

Searched for: Brain Cancer

10 results total

Dose-Intensive Chemotherapy in Combination with Chemoprotected Autologous Stem Cells for Patients with Malignant Gliomas

See details >>

Principal Investigator: Hans-Peter Kiem, MD

Study Number: 2000.00

A Phase II Trial of PTK-787 in Recurrent or Progressive Meningiomas

See details >>

Principal Investigator: Marc Chamberlain, MD

Study Number: 6583

A Phase II Study of Bendamustine in the Treatment of Recurrent High-Grade Gliomas (Anaplastic Gliomas and Glioblastoma)

See details >>

Principal Investigator: Marc Chamberlain, MD

Study Number: 6803

Efficacy of Carboplatin Administered Concomitantly with Radiation and Isoretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients

See details >>

Principal Investigator: James Olson, MD, PhD

Study Number: COG ACNS0332

A Phase I study of VEGF Trap (NSC #72477 ? IND #100137) in Children with Relapsed/Refractory Solid Tumors

See details >>

Principal Investigator: Julie Park, MD

Study Number: COG ADVL0714

A Phase II Study of Conformal Radiotherapy in Patients with Low Grade Gliomas

See details >>

Principal Investigator: J. Russell Geyer, MD

Study Number: COG ACNS0221

A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy 18.00 Gy and Chemotherapy In Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial

See details >>

Principal Investigator: J. Russell Geyer, MD

Study Number: COG ACNS0331

A Phase I study of the Raf kinase and receptor tyrosine kinase inhibitor Sorafenib (BAY 43-9006, NSC# 724772 IND# 69896) in children with refractory solid tumors or refractory leukemias

See details >>

Principal Investigator: Julie Park, MD

Study Number: COG ADVL0413

A Phase I Study of Temozolomide, oral Irinotecan and Vincristine for Children with Refractory Solid Tumors

See details >>

Principal Investigator: Julie Park, MD

Study Number: COG ADVL0414

A Phase II Study of Pemetrexed in Children with Recurrent Malignancies

See details >>

Principal Investigator: Julie Park, MD

Study Number: COG ADVL0525

Search Options

Select a disease from the list below:

Limit results to studies enrolling:
Both Adults & Pediatrics Adults Pediatrics

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.